New
Ind-Swift
Ind-Swift Group is a prominent player in the global pharmaceutical industry, encompassing three key entities: Ind-Swift Laboratories Ltd, a US-FDA approved manufacturer of active pharmaceutical ingredients (APIs); Ind-Swift Ltd, which specializes in the manufacture of finished dosage forms; and Ind-Swift Inc, the US subsidiary.
Description
Ind-Swift Group is a prominent player in the global pharmaceutical industry, encompassing three key entities: Ind-Swift Laboratories Ltd, a US-FDA approved manufacturer of active pharmaceutical ingredients (APIs); Ind-Swift Ltd, which specializes in the manufacture of finished dosage forms; and Ind-Swift Inc, the US subsidiary. With a robust manufacturing footprint comprising seven locations across India and a cutting-edge research and development centre, the Group has established itself as a reliable partner to pharmaceutical companies seeking quality and compliance in regulated markets.
Services include:
- Regulatory Services
- Containment
- APIs (Active Pharmaceutical Ingredients)
- Solid Dosage
- Packaging
Ind-Swift is committed to delivering high-quality products and services to the pharmaceutical sector, reflecting its dedication to excellence. For more information, please visit indswiftlabs.com.
Certification
WHO, Australia TGA, Brazil ANVISA, Canada Health Canada, United States FDA, Europe EMA, Japan PMDA, South Korea MFDS, UK MHRA, ISO 9001, ISO 14001
Capabilities
Contact Information
Website
Phone
Twitter (X)
Address
3500 S Dupont Hwy, Shivalik Enclave, NAC, Manimajra, Chandigarh, Haryana, 160101, India
Zip/Post Code
160101
Stay ahead of trends and best practices
